Novartis AG Total Assets
Novartis AG (NVSEF) had Total Assets of $110.95 billion as of 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:Assets · last filed 2026-02-04
- 2025-12-31: Assets $110.95B.
- 2025-06-30: Assets $104.39B.
- 2024-12-31: Assets $102.25B.
- 2024-06-30: Assets $97.50B.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2025-12-31 | $110.95B 20-F · filed 2026-02-04 | |
| 2025-06-30 | $104.39B 6-K · filed 2025-07-17 | |
| 2024-12-31 | $102.25B 20-F · filed 2026-02-04 | |
| 2024-06-30 | $97.50B 6-K · filed 2024-07-18 | |
| 2023-12-31 | $99.94B 20-F · filed 2025-01-31 | |
| 2023-06-30 | $110.98B 6-K · filed 2023-07-18 | |
| 2022-12-31 | $117.45B 20-F · filed 2024-01-31 | |
| 2022-06-30 | $122.91B 6-K · filed 2022-07-19 | |
| 2021-12-31 | $131.79B 20-F/A · filed 2023-05-15 | |
| 2021-06-30 | $124.02B 6-K · filed 2021-07-21 | |
| 2020-12-31 | $127.78B 20-F · filed 2022-02-02 | $132.06B 20-F · filed 2021-01-26 |
| 2020-06-30 | $123.76B 6-K · filed 2020-07-21 | |
| 2019-12-31 | $118.37B 20-F · filed 2021-01-26 | |
| 2019-06-30 | $116.29B 6-K · filed 2019-07-18 | |
| 2018-12-31 | $145.56B 20-F · filed 2020-01-29 | |
| 2018-06-30 | $142.06B 6-K · filed 2018-07-18 | |
| 2018-01-01 | $133.07B 20-F · filed 2019-01-30 | |
| 2017-12-31 | $133.08B 20-F · filed 2019-01-30 | |
| 2016-12-31 | $130.12B 6-K · filed 2018-01-24 |